MHC class II invariant chain–adjuvanted viral vectored vaccines enhances T cell responses in humans
Strategies to enhance the induction of high magnitude T cell responses through vaccination are urgently needed. Major histocompatibility complex (MHC) class II–associated invariant chain (Ii) plays a critical role in antigen presentation, forming MHC class II peptide complexes for the generation of...
Auteurs principaux: | Esposito, I, Cicconi, P, D'Alise, AM, Brown, A, Esposito, M, Swadling, L, Holst, PJ, Bassi, MR, Stornaiuolo, M, Mori, F, Vassilev, V, Li, W, Donnison, T, Gentile, C, Turner, B, von Delft, A, Del Sorbo, M, Barra, F, Contino, AM, Abbate, A, Novellino, E, Thomsen, AR, Christensen, JP, Lahm, A, Grazioli, F, Ammendola, V, Siani, L, Colloca, S, Klenerman, P, Nicosia, A, Dorrell, L, Folgori, A, Capone, S, Barnes, E |
---|---|
Autres auteurs: | PEACHI Consortium |
Format: | Journal article |
Langue: | English |
Publié: |
American Association for the Advancement of Science
2020
|
Documents similaires
-
Chronic hepatitis C viral infection subverts vaccine-induced T-cell immunity in humans
par: Kelly, C, et autres
Publié: (2016) -
Chronic Hepatitis C Virus infection subverts vaccine induced T-cell immunity in humans.
par: Kelly, C, et autres
Publié: (2016) -
A human vaccine strategy based on chimpanzee adenoviral and MVA vectors that primes, boosts, and sustains functional HCV-specific T cell memory
par: Swadling, L, et autres
Publié: (2014) -
Mucosal delivery of a vectored RSV vaccine is safe and elicits protective immunity in rodents and nonhuman primates
par: Angiolo Pierantoni, et autres
Publié: (2015-01-01) -
Immune responses against a liver-stage malaria antigen induced by simian adenoviral vector AdCh63 and MVA prime-boost immunisation in non-human primates
par: Capone, S, et autres
Publié: (2010)